UK-based Futura Medical plc has struck a deal with Cooper Consumer Health for the launch of its topical, gel-based erectile dysfunction (ED) treatment MED3000 across Europe.
Futura Pens Deal With Cooper To Launch Erectile Dysfunction Gel In Europe
Futura Medical's novel OTC topical erectile dysfunction treatment MED3000 will be launched across numerous European markets by France's Cooper Consumer Health.